Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols

Epidemiology and Infection

Volumn 137, Issue 12, 2009, Pages 1679-1683

  Pakyz, A L ^a   Farr, B M ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Antimicrobial drugs

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; ANTIINFECTIVE AGENT;

ABSCESS; ANTIBIOTIC CYCLING PROTOCOL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BONE INFECTION; CLINICAL PROTOCOL; DISEASE ASSOCIATION; EAR INFECTION; EYE INFECTION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; NOSE INFECTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; STENOTROPHOMONAS MALTOPHILIA; SURGICAL INFECTION; URINARY TRACT INFECTION; GRAM NEGATIVE INFECTION; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK FACTOR; TIME; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; CARRIER STATE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; RETROSPECTIVE STUDIES; RISK FACTORS; STENOTROPHOMONAS MALTOPHILIA; TIME FACTORS;

EID: 70449730673     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002830     Document Type: Article

References (10)

1. Raymond DP, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Critical Care Medicine 2001; 29: 1101-1108.
2. Dellit TH, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 2007; 44: 159-177.
3. Warren DK, et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Critical Care Medicine 2004; 32: 2450-2456.
4. Villarino ME, et al. Risk factors for epidemic Xanthomonas maltophilia/colonization in intensive care unit patients. Infection Control and Hospital Epidemiology 1991; 13: 201-206.
5. Carmeli Y, Samore MH. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia : a historical cohort study. Clinical Infectious Diseases 1997; 24: 1131-1134.
6. Meyer E, et al. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). Journal of Hospital Infection 2006; 64: 238-243. (Pubitemid 44480720)
7. Garner JS, et al. CDC definitions for nosocomial infections. American Journal of Infection Control 1988; 16: 128-140.
8. Wenzel RP, et al. Hospital-acquired infections. I. Surveillance in a university hospital. American Journal of Epidemiology 1976; 103: 251-260.
9. Rosner B. Hypothesis testing : Person-time data. In: Fundamentals of Biostatistics, 5th edn. Pacific Grove, CA: Duxbury Thomson Learning, 2000, pp. 682-686.
10. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clinical Microbiology Reviews 1998; 11: 57-80.